Programmatic is giving marketers new ways to reach relevant audiences while health decisions are top of mind. In the doctor’s office, audience data and context can work together to create a more relevant advertising experience.
Drugmakers get clearer expectations for approvals and patients get a defined role in drug development.
73% say it causes care disruptions—easier access and clearer guidance could help protect patient loyalty.
Its $1.5B insitro deal reflects pharma's enthusiasm for AI despite the lack of commercial payoffs.
Epic Rx price tool lets patients compare cash vs. insurance at the doctor’s office, which could help them secure the lowest-cost drugs.
Social media creators and community ties may help reach audiences outside clinical settings.
Sponsored messages on journal and society sites are most likely to prompt action.
Google expands its health data ecosystem with Flo, Function integrations. Actionable and reliable health guidance will be key to retaining users in a crowded market.
They are creating a new training model to prepare future physicians to use AI in patient care.
AI companies and healthcare providers must ensure transparency about how health information is used and make it easy to revoke or delete access.
Universal Standard’s latest collection shows strong demand for larger sizes even as other apparel brands cut back.
Google tests pharma ads in AI Mode and Overviews, bringing drugmakers closer to consumers' treatment decisions while testing AI search’s readiness for regulated advertising.
As the economy continues to put a strain on many household budgets, a number of consumers are planning to use annual holiday sales to stock up on everyday essentials, as well as buying gifts.
Sponsored health content on social media is competing for attention—brands can differentiate by sharing balanced patient experiences that go beyond product benefits.
And while streaming gained a bigger share of ad dollars, many brands still favor linear TV.
As more healthcare orgs restrict drug rep access, pharma marketers must adopt more targeted, data-driven outreach to sustain their influence on doctors.
The effort aims to speed drug development by pooling research resources and clinical trial infrastructure.
Healthcare AI delivers ROI in half the expected time. As automation expands, healthcare employers will likely cut more back-office jobs.
The case tests federal agency authority to impose drug pricing rules without congressional approval.
Everlywell sells FDA-cleared AI breast cancer risk scores. The tool offers new five-year risk insights, but providers must explain their limitations.